Literature DB >> 23020521

Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma.

Wei-Ren Luo1, Fei Gao, Si-Yi Li, Kai-Tai Yao.   

Abstract

AIMS: To detect the prognostic significance of tumour budding and its expression of aldehyde dehydrogenase 1 (ALDH1) in nasopharyngeal carcinoma (NPC). METHODS AND
RESULTS: Tumour budding was investigated in 105 patients with NPC by immunohistochemistry for pan-cytokeratin (AE1/AE3). The intensity of budding correlated strongly with T classification (P=0.008), lymphatic invasion (P<0.001), vascular invasion (P=0.029), lymph node metastasis (P < 0.001), and clinical stage (P=0.010). Univariate analysis revealed that patients with high budding grade had poorer survival than those with low grade (P=0.002). Multivariate analysis showed that tumour budding was an independent predictor of survival (P=0.001). Furthermore, budding cells showed high-level expression of the cancer stem cell (CSC) marker ALDH1. Budding cells with high-level ALDH1 expression contributed to several aggressive behaviours and poor survival (P=0.000).
CONCLUSIONS: We describe, for the first time, the presence of tumour budding and its correlation with aggressive tumour behaviour and poor patient survival in NPC. The degree of tumour budding could be a valuable predictive factor in NPC. In addition, we show, also for the first time, that budding cells in NPC might possess the invasive and metastatic properties of CSCs.
© 2012 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020521     DOI: 10.1111/j.1365-2559.2012.04350.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  27 in total

1.  Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition.

Authors:  Valeria Maffeis; Rocco Cappellesso; Francesca Galuppini; Vincenza Guzzardo; Alessia Zanon; Diego Cazzador; Enzo Emanuelli; Laura Ventura; Alessandro Martini; Ambrogio Fassina
Journal:  Virchows Arch       Date:  2020-01-24       Impact factor: 4.064

2.  Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies.

Authors:  Alhadi Almangush; Ilmo Leivo; Maria Siponen; Elias Sundquist; Rayan Mroueh; Antti A Mäkitie; Ylermi Soini; Caj Haglund; Pentti Nieminen; Tuula Salo
Journal:  Virchows Arch       Date:  2017-08-02       Impact factor: 4.064

Review 3.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

4.  Predictive Significance of Tumor Depth and Budding for Late Lymph Node Metastases in Patients with Clinical N0 Early Oral Tongue Carcinoma.

Authors:  Yukiko Hori; Akira Kubota; Tomoyuki Yokose; Madoka Furukawa; Takeshi Matsushita; Morihito Takita; Sachiyo Mitsunaga; Nobutaka Mizoguchi; Tetsuo Nonaka; Yuko Nakayama; Nobuhiko Oridate
Journal:  Head Neck Pathol       Date:  2017-04-03

5.  Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.

Authors:  Kazuyuki Saito; Takashi Okuyama; Shunya Miyazaki; Haruka Oi; Takashi Mitsui; Takuji Noro; Emiko Takeshita; Yuko Ono; Taizen Urahashi; Hidehiro Tajima; Hideyuki Yoshitomi
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

6.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review.

Authors:  Raissa Borges Curtarelli; Jussara Maria Gonçalves; Luciane Geanini Pena Dos Santos; Maria Gorete Savi; Jacques Eduardo Nör; Luis André Mendonça Mezzomo; Mabel Mariela Rodríguez Cordeiro
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

Review 7.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

8.  Expression of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors.

Authors:  Tetsuya Tamatani; Natsumi Takamaru; Go Ohe; Kazuya Akita; Takayuki Nakagawa; Youji Miyamoto
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

9.  Immunolocalization of Cancer Stem Cells Marker ALDH1 and its Association with Tumor Budding in Oral Squamous Cell Carcinoma.

Authors:  Helvécio Marangon Junior; Victória Vasconcellos Moreira Melo; Ângela Braga Caixeta; Giovanna Ribeiro Souto; Paulo Eduardo Alencar Souza; Maria Cássia Ferreira de Aguiar; Martinho Campolina Rebello Horta
Journal:  Head Neck Pathol       Date:  2018-11-14

10.  Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.

Authors:  Yuri Noda; Mitsuaki Ishida; Yasuhiro Ueno; Takuo Fujisawa; Hiroshi Iwai; Koji Tsuta
Journal:  BMC Cancer       Date:  2022-04-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.